Related references
Note: Only part of the references are listed.Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors
P. W. Raake et al.
GENE THERAPY (2008)
Percutaneous cardiac recirculation-mediated gene TranSimer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals
David M. Kaye et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Targeting the heart with gene therapy-optimized gene delivery methods
Oliver J. Mueller et al.
CARDIOVASCULAR RESEARCH (2007)
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
Christina A. Pacak et al.
CIRCULATION RESEARCH (2006)
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Katsuya Inagaki et al.
MOLECULAR THERAPY (2006)
Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors
OJ Müller et al.
CARDIOVASCULAR RESEARCH (2006)
Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors
C Mah et al.
GENE THERAPY (2005)
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade
M Hayase et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Excessive sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression causes increased sarcoplasmic reticulum Ca2+ uptake but decreases myocyte shortening
N Teucher et al.
CIRCULATION (2004)
Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors
D Chu et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes
B Fiedler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery
M Hoshijima et al.
NATURE MEDICINE (2002)
Calcium cycling in congestive heart failure
G Hasenfuss et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene
LG Melo et al.
CIRCULATION (2002)
Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: Amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters
T Kawada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo
MJ Wright et al.
GENE THERAPY (2001)
Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca2+-ATPase in a rat model of heart failure
F del Monte et al.
CIRCULATION (2001)
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
MI Miyamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
